Using anti-PD-L1 IHC staining (Figure 6A), more anti-PD-L1 accumulated in SHD-RT-treated tumor tissues (Figure 6B), which supported the view that the increased perfusion did favor drug delivery. The gene discussed is CD274; the disease is neoplasm.